Sign Up Today and Learn More About Virool Stock
Invest in or calculate the value of your shares in Virool or other pre-IPO companies through EquityZen's platform.
About Virool Stock
Founded
2012
Total Funding
18.6M
Industries
Software, Artificial Intelligence, Data and Analytics
Virool is a programmatic video marketing platform for individuals, small businesses and global brands and their agencies. More than 30,000 global advertisers are using the Virool platform to promote their video messages, engage their audience and elevate their brand.
Leveraging precise audience targeting and a fully transparent and insightful analytics suite, Virool offers custom creative solutions that enable one-click social sharing. More than 100,000 online and mobile publisher properties have run video content from Virool via programmatic partnerships, native placements and direct integrations.
Having served more than 60,000 video advertising campaigns, Virool is trusted by some of the biggest brands in the world including Coca-Cola, Red Bull, Disney, Sony, Anheuser-Busch, Turkish Airlines, Intel, and Levi's.
Virool Press Mentions
Stay in the know about the latest news on Virool
Virool raises $12M for native video ads
TechCrunch • Apr 05, 2016
YC-Backed Virool Raises $6.62 Million “Seed” Round To Help Make Videos Go Viral
TechCrunch • Feb 14, 2013
Investors in Virool
Discover investors in Virool stock and explore their portfolio companies
Virool Management
Leadership team at Virool
Cofounder and CEO
Alexander Debelov
Cofounder
Vladimir Gurgov
Join now and verify your accreditation status to gain access to:
- Virool current valuation
- Virool stock price
- Available deals in Virool and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Virool stock?
Accredited investors can buy pre-IPO stock in companies like Virool through EquityZen funds. These investments are made available by existing Virool shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Virool stock?
Shareholders can sell their Virool stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."